COVID-19 Science Updates
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
5 Scandinavian countries limit or halt Moderna
Five Scandinavian countries limit or halt Moderna
Oct 13, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
5 Scandinavian countries limit or halt Moderna
Copy link
Facebook
Email
Notes
More
Effectiveness Moderna vaccine vs. Delta, Mu, and other emerging variants
Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants
Oct 8, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Effectiveness Moderna vaccine vs. Delta, Mu, and other emerging variants
Copy link
Facebook
Email
Notes
More
Molnupiravir, an oral antiviral treatment for COVID-19
Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, Merck reports
Oct 6, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Molnupiravir, an oral antiviral treatment for COVID-19
Copy link
Facebook
Email
Notes
More
Efficient border testing via reinforcement learning
Efficient and targeted COVID-19 border testing via reinforcement learning
Oct 4, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Efficient border testing via reinforcement learning
Copy link
Facebook
Email
Notes
More
UK Committee opts not to recommend vaccination of 12-15 year olds
Covid-19: JCVI opts not to recommend universal vaccination of 12-15 year olds
Oct 2, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
UK Committee opts not to recommend vaccination of 12-15 year olds
Copy link
Facebook
Email
Notes
More
September 2021
Immunity from natural infection vs vaccination: systematic review
Equivalency of Protection from Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
Sep 29, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Immunity from natural infection vs vaccination: systematic review
Copy link
Facebook
Email
Notes
More
1
Reinfection by Gamma variant in Manaus, Brazil
Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
Sep 27, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Reinfection by Gamma variant in Manaus, Brazil
Copy link
Facebook
Email
Notes
More
Vaccine effectiveness in the US: Moderna 93%, Pfizer 88%, J&J 71%
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults…
Sep 24, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Vaccine effectiveness in the US: Moderna 93%, Pfizer 88%, J&J 71%
Copy link
Facebook
Email
Notes
More
J&J says 2 doses 100% effective against severe Covid
Johnson & Johnson says additional dose boosts Covid vaccine efficacy
Sep 23, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
J&J says 2 doses 100% effective against severe Covid
Copy link
Facebook
Email
Notes
More
Vaccines in children and adolescents: a systematic review
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccine in Children and Adolescents: A Systematic Review
Sep 20, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Vaccines in children and adolescents: a systematic review
Copy link
Facebook
Email
Notes
More
Why vaccinate people who have had Covid?
Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US?
Sep 17, 2021
•
Carl Juneau, PhD
1
Share this post
COVID-19 Science Updates
Why vaccinate people who have had Covid?
Copy link
Facebook
Email
Notes
More
Booster shots: what is the evidence?
What’s the evidence for COVID-19 booster shots?
Sep 16, 2021
•
Carl Juneau, PhD
Share this post
COVID-19 Science Updates
Booster shots: what is the evidence?
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts